![RI, NRM, LFS, and OS by donor type. The 2-year RI was 28.6% (95% CI, 25.1-32.2) for older MSDs, significantly higher than for young HIDs (20.1% [95% CI, 16.4-24.2]; P < .001) (A). The 2-year cumulative incidence of NRM was lower for older MSDs (14.7% [95% CI, 12-17.6]) than for young HIDs (24.4% [95% CI, 20.4-28.6]; P < .001) (B). The 2-year probability of LFS was 56.7% (95% CI, 52.7-60.5) for older MSDs vs 55.5% (95% CI, 50.5-60.3) for young HIDs (P = .73) (C). The 2-year probability of OS was 62.9% (95% CI, 58.9-66.7) for older MSDs vs 62% (95% CI, 57-66.6) for young HIDs (P = .29) (D).](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/9/20/10.1182_bloodadvances.2024015582/1/blooda_adv-2024-015582-gr2.jpeg?Expires=1764053172&Signature=gcRNlyNYPRHTFiKG6nTIJ51WKZ84QMlzwd3TNGbDey4PwdvNVQ76mWl6vlNW3vHXH0YXmJ0cpCW7L6Wi~tE1FftFWWRQbRvodxLgYVrkbvBr0jfraDaTBliTaNr-iQqwr3sxBFU~wsEzCiRC044GkD6yp4c0wnopJAysI1cKqZBQz~rVVyMMJLTR5mNwo1OelwVkTkH-MMVuUwKPnLElTEd8Th8X9TLUoVIBJwpYP--L16PqrcVqEf40OujtTxxQ1jLZsi9QtuSWQ~owD2NOYvWL-3NdngYek48EL6tPrNQRBvNJ6~P53vhDW20ALPMM297RRtYsuPFYxTdEozlgqQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Figure 2.
RI, NRM, LFS, and OS by donor type. The 2-year RI was 28.6% (95% CI, 25.1-32.2) for older MSDs, significantly higher than for young HIDs (20.1% [95% CI, 16.4-24.2]; P < .001) (A). The 2-year cumulative incidence of NRM was lower for older MSDs (14.7% [95% CI, 12-17.6]) than for young HIDs (24.4% [95% CI, 20.4-28.6]; P < .001) (B). The 2-year probability of LFS was 56.7% (95% CI, 52.7-60.5) for older MSDs vs 55.5% (95% CI, 50.5-60.3) for young HIDs (P = .73) (C). The 2-year probability of OS was 62.9% (95% CI, 58.9-66.7) for older MSDs vs 62% (95% CI, 57-66.6) for young HIDs (P = .29) (D).
